The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLTA.L Regulatory News (FLTA)

  • There is currently no data for FLTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Filta Group Holdings plc

24 Feb 2022 15:57

RNS Number : 7627C
Filta Group Holdings PLC
24 February 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Filta Group Holdings plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Filta Group Holdings plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

23 February 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Ordinary Shares held by directors of Filta Group Holdings plc or persons acting in concert

 

Name

Identity

Number of Filta Shares

Approximate percentage of issued share capital

Jason Sayers

Executive Director

3,688,120

12.66

Roy Sayers

Non-Executive Director

562,160

1.93

the Meredian Settlement Trust*

Sayer's Family Trust

7,926,560

27.20

Victor Clewes

Executive Director

4,558,750

15.65

Jlubomir Urosevic

Executive Director

1,359,690

4.67

Tim Worlledge

Non-Executive Chairman

56,700

0.19

Graham Woolfman

Non-Executive Director

18,000

0.06

Lloyd Martin

Non-Executive Director

5,235

0.02

 

* Roy Sayers is the settlor and trustee of the Trust. Jason Sayers is a life tenant and he and Mrs Dawn Sayers, wife of Roy Sayers, are the beneficiaries of the Trust.

 

Options and awards held by directors of Filta Group Holdings plc or persons acting in concert

 

No options over Filta Shares have been granted to the Filta Directors and their respective immediate families, related trusts and connected persons under the Filta EMI Plan, neither have they been granted to anyone person acting in concert with Filta. However, under the Filta SARs Plan*, which is a cash plan, the following remained outstanding:

 

Director

Maximum Number of SARS

SARS award price

Date of Grant

Expiry Date

Brian Hogan

90,000

0.97

05/05/2017

04/05/2027

Brian Hogan

15,000

2.15

11/01/2019

11/01/2029

Brian Hogan

15,000

2.15

11/01/2019

11/01/2029

Brian Hogan

15,000

2.30

15/05/2019

15/05/2029

Brian Hogan

15,000

2.30

15/05/2019

15/05/2029

Brian Hogan

15,000

0.97

15/07/2020

15/07/2030

Brian Hogan

15,000

0.97

15/07/2020

15/07/2030

 

* a share acquisition rights scheme (SARs), which is an employee incentive scheme implemented by Filta for the benefit of employees in the US which follows the structure of the Filta EMI Plan to provide holders of SARs 'options' with the same reward value as if the SARs were options over shares in Filta, save that the reward is provided in cash and does not involve the issue of Filta shares.

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

24 February 2022

Contact name:

Brian Hogan

Telephone number:

+1 407 996 5550

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEASALASSAEFA
Date   Source Headline
9th Sep 20197:00 amRNSInterim Results
23rd Aug 20193:00 pmRNSNotice of Results
28th Jun 20197:00 amRNSDirector/PDMR Shareholding
27th Jun 20191:41 pmRNSIssue of Equity
25th Jun 20194:17 pmRNSIssue of Equity
12th Jun 20191:23 pmRNSResult of AGM
12th Jun 20197:00 amRNSAGM Statement
28th May 20194:50 pmRNSIssue of Equity
16th May 20195:27 pmRNSDirector/PDMR Shareholding
8th May 20196:05 pmRNSPosting of Annual Report and Notice of AGM
29th Apr 20194:49 pmRNSHolding(s) in Company
15th Apr 201912:30 pmEQSHardman & Co Research: Filta Group (FLTA): Strong and transformative year in 2018
15th Apr 20197:00 amRNSFinal Results
3rd Apr 201911:11 amEQSHardman & Co Research: Filta Group (FLTA) Initiation: Cleaning up in commercial catering
25th Mar 20195:11 pmRNSHolding(s) in Company
21st Mar 20198:30 amRNSCompletion of Acquisition & Total Voting Rights
18th Feb 20197:00 amRNSAppointment of Non-Executive Director
15th Feb 20194:30 pmRNSReplacement - Pre-Close Trading Update
14th Feb 20197:00 amRNSPre-Close Trading Update
1st Feb 20197:00 amRNSIssue of Equity & Director/PDMR Shareholding
25th Jan 20193:40 pmRNSAwards of share options & appreciation rights
21st Dec 20185:15 pmRNSHolding(s) in Company
21st Dec 20185:00 pmRNSHolding(s) in Company
20th Dec 20182:02 pmRNSHolding(s) in Company
19th Dec 20181:00 pmRNSAcquisition of Watbio Holdings Limited
13th Dec 201811:19 amRNSHolding(s) in Company
13th Dec 201811:18 amRNSHolding(s) in Company
6th Sep 201812:00 pmRNSHolding(s) in Company
4th Sep 20187:00 amRNSInterim Results
10th Aug 20187:00 amRNSPre-Close Trading Update
5th Jun 201812:11 pmRNSResult of AGM
5th Jun 20187:00 amRNSTrading Update
11th May 20187:00 amRNSPosting of AR&A, AGM notice & Dividend Declaration
17th Apr 20187:00 amRNSFinal Results
7th Feb 20187:00 amRNSPre-Close Trading Update
31st Jan 20187:00 amRNSPurchase of FiltaFry Deutschland GmbH
4th Jan 20181:16 pmRNSSale of Refrigeration and HVAC business
23rd Nov 20177:00 amRNSExercise of Options
7th Sep 20177:00 amRNSInterim Results
22nd Aug 20177:00 amRNSAcquisition of Grease Management Ltd
7th Aug 20177:00 amRNSTrading update
1st Jun 201711:21 amRNSResult of AGM
1st Jun 20177:00 amRNSTrading Update
8th May 201711:40 amRNSAwards of options and share appreciation rights
8th May 201711:36 amRNSPosting of Accounts,AGM notice and Maiden Dividend
3rd Apr 20177:00 amRNSPreliminary Results
10th Mar 20177:00 amRNSNotice of Results
19th Jan 20177:00 amRNSReduction of Capital
4th Jan 20175:25 pmRNSDirector/PDMR Shareholding
4th Nov 20167:00 amRNSAdmission and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.